| Literature DB >> 25530778 |
Da-Chao Wen1, Yi-Bei Li2, Xiao-Yu Hu1, Wu Lin1, Ling-Yan Jia1, Sen Zhong1.
Abstract
ASF composed by semen and epimedium herbal is a traditional plant compound that is widely used in the treatment of insomnia. Studies have shown that saponins and flavonoids contained in semen can significantly decrease the content of excitatory neurotransmitter Glu in mice. And the total flavone of YinYangHuo can increase the release of GABA in the anterior periventricular system of rat and increase the affinity of GABA for the receptors GABAA. It can be inferred that their synergism may have effect on the neurotransmitter that causes behavioral sensitization and conditioned place preference in experimental animals and affects their drinking behaviors, which is the starting point of this research. The present study found that ASF can inhibit development and expression of behavioral sensitization induced by ethanol and the development of CPP in mice. We demonstrate the inhibition of ASF on behavioral sensitization partly due to its effect on the mesolimbic neurotransmitter system, including decreasing level of DA and Glu and increasing the content of GABA. It suggested that the ASF may have pharmacological effects in the treatment of alcohol addiction.Entities:
Year: 2014 PMID: 25530778 PMCID: PMC4229967 DOI: 10.1155/2014/304718
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
The formula of ASF (one dose).
| Herb | Medicinal parts | Origin | Amount in preparation (g) |
|---|---|---|---|
| Ziziphus jujuba | |||
| Mill. var. spinosa | Fruit | Hebei Province | 30 |
| Epimedium brevicornu | Rhizoma and Leaf | Shanxi Province | 24 |
Experimental groups and treatments. Pretreatment drug administration (i.g.) was given 30 min before treatment.
| Group | Treatment phase | Challenge phase | ||||
|---|---|---|---|---|---|---|
| Days 1, 3, 5, 7, and 9 | Day 11 (saline challenge) | Day 13 (drug challenge) | ||||
| Pretreatment | Treatment | Pretreatment | Treatment | Pretreatment | Treatment | |
| S + S | Saline | Saline | Saline | Saline | Saline | Ethanol |
| ASF | Saline | |||||
| ASF | Ethanol | |||||
|
| ||||||
| Z + S | ASF | Saline | Saline | Saline | Saline | Ethanol |
| ASF | Saline | |||||
| ASF | Ethanol | |||||
|
| ||||||
| S + E | Saline | Ethanol | Saline | Saline | Saline | Ethanol |
| ASF | Saline | |||||
| ASF | Ethanol | |||||
|
| ||||||
| Z + E | ASF | Ethanol | Saline | Saline | Saline | Ethanol |
| ASF | Saline | |||||
| ASF | Ethanol | |||||
Figure 1Timeline of CPP procedure.
Figure 3Spontaneous activity (mean ± SEM, counts in 15 min) in the 5 tests during the 10-day period of treatment, immediately after ethanol or saline administration. Mice were pretreated with ASF or saline 30 mins before the test (data were analysed by One-way repeat measures ANOVA and followed by Bonferroni posttest). Groups: saline + saline (S + S, n = 30), ASF + saline (Z + S, n = 30), saline + ethanol 2.2 g/kg (S + E, n = 30), and ASF + ethanol 2.2 g/kg (Z + E, n = 30). *Higher levels than S + S group in tests 1, 2, 3, 4, and 5 (P < 0.01). #Higher activity levels than in tests 1 2, and 3 (P < 0.05), ▲Z + E group Higher levels than S + S group, Z + S group in tests 4 and 5 (P < 0.05), ▼S + E group Higher levels than Z + S group in 2, 3, 4, and 5 tests (P < 0.01).
Figure 4Spontaneous activity (mean ± SEM, counts in 15 min) in challenge tests of mice previously treated with (a) saline + saline (S + S); (b) 8.1 g/kg of ASF + saline (Z + S); (c) saline + 2.2 g/kg of ethanol (S + E); and (d) 8.1 g/kg of ASF + 2.2 g/kg of ethanol (Z + E). All animals were tested under saline + saline (saline challenge) with 30 min of interval between saline and saline administration “Drug challenge” was assigned 48 h after “saline challenge.” Different animals were used in each “Drug challenge.” Saline + 2.2 g/kg of ethanol (ethanol; n = 10); saline + ASF 8.1 g/kg (ASF; n = 10); and ASF 8.1 g/kg + ethanol 2.2 g/kg (ASF + ethanol; n = 10). The mice were tested in the spontaneous activity cages for 15 min immediately after ethanol (or saline) administration. #Higher activity levels than those from all other treatment groups in the saline challenge (P < 0.05). *Higher spontaneous activity levels than all the other groups, in all drug challenges (P < 0.01).
Figure 7Effect of ASF on development of ethanol-induced CPP in mice (mean ± SEM, n = 12), ** P < 0.01 versus NS group, # P < 0.05 versus ethanol group (a paired Student's t-test).